logo
Plus   Neg
Share
Email

3M FY20 Outlook Remains Withdrawn; Sees Sales Improvements Beginning In Q3

While reporting financial results for the second quarter on Tuesday, 3M Co. (MMM) said its guidance for the full-year 2020 remains withdrawn as it is not able to estimate the full duration, magnitude and pace of recovery across its diverse end markets with reasonable accuracy, due to the continued evolving and uncertain impact of the COVID-19 pandemic.

The company had withdrawn its fiscal 2020 outlook in late April, due to COVID-19 impact and end-market uncertainty.

The company said it is now seeing broad-based sales improvements across businesses and geographies to start the third quarter. With one week left in July, total company sales are currently up low-single digits year-on-year.

3M will maintain its monthly reporting of sales information during the third-quarter to provide transparency on its ongoing business performance.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT